FIELD: medicine; chemical-pharmaceutical industry.
SUBSTANCE: pharmaceutical formulation contains antibiotic or sulphanilamide and lactulose, and antibiotic particles included are from 20 to 160 mcm, sulphanilamide particles are from 40 to 150 mcm, and lactulose particles are up to 0.3 mm and of purity not less than 97%, antibiotic-lactulose proportion is from 1:0.1 to 1:100, and sulphanilamide-lactulose proportion is 1:12; pharmaceutical formulation is injected 2-3 times a day.
EFFECT: provides accelerated epithelisation of defects of mucous coat of stomach, duodenum or uterine neck; stimulates lactobacilli and bifidus bacteria action.
9 cl, 9 ex
